Apogee Therapeutics, Inc. (APGE) Ownership

$75.50

$0.95 (1.27%)
Last update: 04:00 PM EST
Day's range
$73.51
Day's range
$76.99

Apogee Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VR ADVISER, LLC 11/14/2025 8.49 M $337.44 M   0.00% 14.54%
FMR LLC 11/13/2025 6.92 M $274.79 M   0.14% 11.84%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 4.72 M $187.67 M   24.12% 8.08%
RTW INVESTMENTS, LP 11/14/2025 2.71 M $107.75 M   0.00% 4.64%
BLACKROCK, INC. 11/12/2025 2.69 M $106.72 M   4.82% 4.60%
VANGUARD GROUP INC 11/07/2025 2.25 M $89.22 M   6.48% 3.84%
DRIEHAUS CAPITAL MANAGEMENT LLC 11/14/2025 2.16 M $85.76 M   -6.59% 3.69%
FAIRMOUNT FUNDS MANAGEMENT LLC 11/14/2025 2.05 M $81.39 M   0.00% 3.51%
STATE STREET CORP 11/14/2025 1.66 M $65.77 M   31.47% 2.83%
PARADIGM BIOCAPITAL ADVISORS LP 11/14/2025 1.52 M $60.46 M   58.74% 2.60%
BRAIDWELL LP 11/14/2025 1.44 M $57.16 M   -2.69% 2.46%
ALLIANCEBERNSTEIN L.P. 11/14/2025 1.42 M $56.38 M   2.23% 2.43%
PERCEPTIVE ADVISORS LLC 11/14/2025 1.35 M $53.71 M   14.37% 2.31%
AFFINITY ASSET ADVISORS, LLC 11/13/2025 1.17 M $46.62 M   69.60% 2.01%
CITADEL ADVISORS LLC 11/14/2025 1.17 M $46.45 M   135.90% 2.00%
JPMORGAN CHASE & CO 11/26/2025 1.14 M $45.20 M   1.08% 1.95%
MERCER GLOBAL ADVISORS INC /ADV 11/14/2025 970.58 K $38.56 M   18.31% 1.66%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 892.20 K $35.45 M   14.00% 1.53%
UBS GROUP AG 11/13/2025 799.47 K $31.76 M   646.07% 1.37%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 750.53 K $29.82 M   -1.36% 1.28%
FRANKLIN RESOURCES INC 11/13/2025 730.76 K $29.03 M   -14.28% 1.25%
BARCLAYS PLC 11/12/2025 642.32 K $25.52 M   5.50% 1.10%
GOLDMAN SACHS GROUP INC 11/14/2025 599.62 K $23.82 M   -9.04% 1.03%
JEFFERIES FINANCIAL GROUP INC. 11/13/2025 568.08 K $22.57 M   -11.56% 0.97%
SOFINNOVA INVESTMENTS, INC. 11/14/2025 565.42 K $22.46 M   642.21% 0.97%
POLAR CAPITAL HOLDINGS PLC 11/14/2025 524.09 K $20.82 M   5.88% 0.90%
NOVO HOLDINGS A/S 11/14/2025 500.00 K $19.87 M   11.26% 0.86%
JANUS HENDERSON GROUP PLC 11/14/2025 485.98 K $19.31 M   -4.58% 0.83%
MORGAN STANLEY 11/14/2025 464.96 K $18.47 M   -2.05% 0.80%
MILLENNIUM MANAGEMENT LLC 11/14/2025 430.46 K $17.10 M   75.60% 0.74%
VESTAL POINT CAPITAL, LP 11/14/2025 425.00 K $16.89 M   100.00% 0.73%
FIRST TURN MANAGEMENT, LLC 11/14/2025 402.81 K $16.00 M   29.32% 0.69%
BANK OF AMERICA CORP /DE/ 11/14/2025 393.91 K $15.65 M   -22.61% 0.67%
FRONTIER CAPITAL MANAGEMENT CO LLC 11/14/2025 374.41 K $14.88 M   21.14% 0.64%
OPALEYE MANAGEMENT INC. 11/14/2025 363.26 K $14.43 M   100.00% 0.62%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 319.90 K $12.71 M   20.09% 0.55%
GREAT POINT PARTNERS LLC 11/14/2025 304.00 K $12.08 M   100.00% 0.52%
COMMODORE CAPITAL LP 11/14/2025 290.00 K $11.52 M   0.00% 0.50%
NORTHERN TRUST CORP 11/14/2025 284.48 K $11.30 M   7.68% 0.49%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2025 235.00 K $9.34 M   -81.79% 0.40%
VICTORY CAPITAL MANAGEMENT INC 11/12/2025 217.21 K $8.63 M   -14.74% 0.37%
SCHRODER INVESTMENT MANAGEMENT GROUP 11/13/2025 215.85 K $8.60 M   81.01% 0.37%
TANG CAPITAL MANAGEMENT LLC 11/14/2025 200.00 K $7.95 M   0.00% 0.34%
BLACKSTONE INC. 11/14/2025 190.35 K $7.56 M   6.61% 0.33%
SG AMERICAS SECURITIES, LLC 10/23/2025 134.23 K $5.33 M   100.00% 0.23%
GRANAHAN INVESTMENT MANAGEMENT, LLC 11/14/2025 132.40 K $5.26 M   0.96% 0.23%
UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 10/30/2025 131.44 K $5.22 M   4.46% 0.23%
CAPITAL WORLD INVESTORS 11/13/2025 127.62 K $5.07 M   -34.18% 0.22%
DIADEMA PARTNERS LP 11/14/2025 127.40 K $5.06 M   -18.49% 0.22%
CANDRIAM S.C.A. 11/06/2025 126.08 K $5.01 M   100.00% 0.22%

Apogee Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 214 institutional investors and hedge funds held shares of Apogee Therapeutics, Inc.. The most heavily invested institutionals were:

VR Adviser, LLC: 8.49 M

FMR LLC: 6.92 M

WELLINGTON MANAGEMENT GROUP LLP: 4.72 M

RTW INVESTMENTS, LP: 2.71 M

BlackRock, Inc.: 2.69 M

VANGUARD GROUP INC: 2.25 M

101.98% of Apogee Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 63.31 M shares in the last 24 months. This purchase volume represents approximately $4.78 B in transactions.